{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:04:26Z","timestamp":1772881466759,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.transproceed.2013.02.137","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T05:47:07Z","timestamp":1379051227000},"page":"2849-2853","source":"Crossref","is-referenced-by-count":4,"title":["Fludarabine, Low-Dose Cyclophosphamide and Rabbit Antithymocyte Globulin Allowed Stable Engraftment After Allogeneic Peripheral Blood Stem Cell Transplantation for Poly-Transfused Dyskeratosis Congenita Patient: Case Report"],"prefix":"10.1016","volume":"45","author":[{"given":"A.","family":"Coli\u0163\u0103","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tanase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Varady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Coli\u0163\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Arion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2013.02.137_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","article-title":"Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation","volume":"11","author":"De la Fuentes","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib2","first-page":"480","article-title":"Dyskeratosis congenita","author":"Dokal","year":"2011","journal-title":"ASH Educational Book Hematology"},{"key":"10.1016\/j.transproceed.2013.02.137_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1996.424984.x","article-title":"Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita","volume":"92","author":"Langston","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib4","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood.V80.12.3090.3090","article-title":"Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements","volume":"80","author":"Dokal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2013.02.137_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00043426-198822000-00002","article-title":"Bone marrow transplantation for severe aplastic anemia associated with dyskeratosis congenita","volume":"10","author":"Conter","year":"1988","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00320601","article-title":"Marrow transplantation for pancytopenia in dyskeratosis congenita","volume":"51","author":"Mahmoud","year":"1985","journal-title":"Blut"},{"key":"10.1016\/j.transproceed.2013.02.137_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2141.1991.tb04543.x","article-title":"Late vascular complications after bone marrow transplantation for dyskeratosis congenita","volume":"79","author":"Berthou","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","article-title":"Unusual complications after bone marrow transplantation for dyskeratosis congenita","volume":"103","author":"Rocha","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2141.1999.01437.x","article-title":"Bone marrow transplant for dyskeratosis congenita","volume":"105","author":"Lau","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1700674","article-title":"Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation","volume":"19","author":"Yabe","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1399-3046.1999.00062.x","article-title":"Hematopoietic stem cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experience","volume":"3","author":"Shaw","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease specific hematopoietic cell trasplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bmt.1701567","article-title":"Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation","volume":"23","author":"Ghavamzadeh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2141.2002.03822.x","article-title":"A\u00a0novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome","volume":"119","author":"Cossu","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.20696","article-title":"Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin","volume":"49","author":"Ayas","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transproceed.2013.02.137_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bmt.1703844","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita","volume":"31","author":"G\u00fcng\u00f6r","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1365-2141.2002.03835_2.x","article-title":"Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine based reduced\u2013intensity conditioning regimen","volume":"119","author":"Nobili","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbmt.2006.11.015","article-title":"Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure","volume":"13","author":"Ostronoff","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00000421-200304000-00023","article-title":"Low-dose radiation for posttransplant lymphoproliferative disorder","volume":"26","author":"Kang","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":"Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1\/2 study","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2013.02.137_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1703931","article-title":"Low-intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in dyskeratosis congenita","volume":"31","author":"Dror","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bmt.1705171","article-title":"Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite a low-intensity conditioning regimen","volume":"36","author":"Brazzola","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","article-title":"Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan","volume":"40","author":"Amarasinghe","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/bmt.2008.163","article-title":"Unrelated cord blood transplantation in a girl with Hoyeraal-Hreidarsson syndrome","volume":"42","author":"Coman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2013.02.137_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2008.07364.x","article-title":"Double cord blood transplantation in patients with high risk bone marrow failure syndromes","volume":"143","author":"Ruggeri","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2013.02.137_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000318721","article-title":"Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita","volume":"124","author":"Vuong","year":"2010","journal-title":"Acta Haematol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513005873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513005873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:12:22Z","timestamp":1596499942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134513005873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0041134513005873"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.02.137","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}